Back To Schedule
Wednesday, March 15 • 1:00pm - 1:45pm
Panel: Conducting a Thorough and Effective IP Due Diligence Review: Uncovering the IP Issues that can Derail the Deal

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
  • Overview of the current status of IP law – what new areas to look out for – written description, antibodies etc.
  • Evaluating IP in platform deals
  • Identifying any ownership conflicts or infringement risks
  • Ways to address the IP problems to save the deal
  • Making a patent portfolio attractive to buyers
  • Patent term extensions and exclusivity analysis
  • Impact of the IP analysis on valuation

avatar for Olga Zimmerman

Olga Zimmerman

Director, Intellectual Property, Caribou Biosciences
Olga is Director, Intellectual Property at Caribou Biosciences where she is responsible for all aspects of intellectual property, including patent and trademark prosecution, freedom to operate reviews and due diligence analysis. Prior to Caribou, Olga served as Senior Counsel, Intellectual... Read More →

avatar for Forrester Liddle

Forrester Liddle

Vice President, Intellectual Property and Contracts, Jounce Therapeutics, Inc.
avatar for Lindsey Wanner, JD

Lindsey Wanner, JD

Associate General Counsel, IP Alliance and Due Diligence, Gilead Sciences
Lindsey is an IP lawyer with over 18 years of experience working in life sciences. She has deep expertise in pharmaceutical patent practice. She leads IP due diligence teams and assists in contract negotiation to support strategic transactions.
avatar for William Coppola

William Coppola

Former Vice President, Intellectual Property, Aerie Pharmaceuticals

Wednesday March 15, 2023 1:00pm - 1:45pm PDT
Hyatt Centric Fisherman's Wharf San Francisco